IP Library Granted Patent US 8,313,782
Granted Patent B2
US 8,313,782 · App. 13/140,559 · Granted Nov 20, 2012

Acne vulgaris treatment regimen

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,313,782
App. No.
13/140,559
Granted
Nov 20, 2012
Kind
B2
Abstract

An improved method, formulation and kit for the treatment of acne vulgaris are disclosed. The formulation is effective in inhibiting or killing the Proprionibacterium microorganism without utilizing antibiotics A preferred formulation alleviates the four pathogenic factors involved in the development of acne a) the putative pathogen of acne, Proprionibacterium acnes , b) abnormal desquamation of sebaceous-follicle epithelium (comedogenesis), c) the androgen-induced excessive sebum production, and d) the follicular reactivity (inflammation). The formulations are preferably applied as a cream, lotion or an emulsion.

Claims (7)

1. A method for treating acne in a patient in need thereof consisting essentially of applying therapeutically effective amounts of zinc pyrithione, linoleic acid, and a substance selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof, to said patient's skin.

2. The method of claim 1 , wherein said therapeutically effective amount of zinc pyrithione is from about 1.0% to about 2.5%.

3. A method for treating acne in a patient in need thereof consisting essentially of applying therapeutically effective amounts of zinc pyrithione, linoleic acid, a substance selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof, and a substance selected from the group consisting of salicylic acid, retinaldehyde, and combinations thereof, to said patient's skin.

4. A method for treating acne in a patient in need thereof consisting essentially of applying therapeutically effective amounts of zinc pyrithione, linoleic acid, a substance selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof, and a substance selected from the group consisting of gamma-linolenic acid, alpha-linolenic acid, cis 4,7,10,13,16,19-docosahexaenoic acid, cis-6,9,12,15-octatetraenoic acid, palmitoleic acid, oleic acid, myristoleic acid, pyridoxine hydrochloride, azelaic acid, green tea extract, arachidonic acid, and combinations thereof, to said patient's skin.

5. A method for treating acne in a patient in need thereof consisting essentially of applying therapeutically effective amounts of zinc pyrithione, linoleic acid, a substance selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof, and a substance selected from the group consisting of ethyl laurate, ethyl linoleate, beta-sitosterol and combinations thereof, to said patient's skin.

6. A method for treating acne in a patient in need thereof consisting essentially of applying therapeutically effective amounts of zinc pyrithione, linoleic acid, a substance selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof, and a substance selected from the group consisting of Vitamin E, nordihydroguaiaretic acid, dexpanthenol, and combinations thereof, to said patient's skin.

7. A method for treating acne in a patient in need thereof consisting essentially of applying therapeutically effective amounts of zinc pyrithione, linoleic acid, a substance selected from the group consisting of propyl gallate, n-octyl gallate, n-dodecyl gallate, and combinations thereof, and glycyrrhetinic acid, to said patient's skin.

Continuity (2)
Provisional Application 61138579 · Dec 18, 2008
Related Publication 20110318434A1 · Dec 29, 2011